Clinical Trial

DEBSCAN-IVL. Drug Eluting Balloon or Drug Eluting Stent to Treat CAlcified Nodules After IntraVascular Lithotripsy.

Study acronym: DEBSCAN-IVL
Recruiting
View on ClinicalTrials.gov →
Summary
International, investigator-driven, multicenter, open-label, prospective randomized controlled trial where patients with de novo lesions due to calcified nodules (CN) were randomized to drug eluting balloon (DEB) or drug eluting stents (DES).
Protocol Amendment History 15 amendments
This ClinicalTrials.gov record has been amended 15 times since 2024-10-23; most recent amendment 2026-06-15.
Status change: Not Yet Recruiting → Recruiting 2025-01-21
Trial Details
NCT Number NCT06657833
Lead Sponsor Fundación EPIC
Conditions Coronary Artery Disease
Enrollment 128 participants
Start Date 2024-12-17
Primary Completion 2027-10-30 (estimated)
Study Completion 2027-10-30 (estimated)
Updated on ClinicalTrials.gov 2026-08-04